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Abstract

Background: Quality of life (QoL) has become increasingly important in cancer treatment. It refers to the patient’s
perception of the effects of the disease and therapy, and their impact on daily functioning and general feeling of
well being.
Material and Methods: In this prospective study, a total of 100 patients treated at our institution, completed the
European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire and the specific
EORTC QLQ-H&N35 module. The questionnaires were distributed to the patients between 12 and 60 months
postoperatively.
Results: Global QoL score was 58.3 and mean score for functioning scale was 76.7. Fatigue (28.7 ± 26.1), followed
by financial problems (27.7 ± 33.5), insomnia (26.7 ± 34.5) and pain (26.3 ± 29.9) had highest symptom score on
QLQ-C30. Fatigue (r=-0.488), insomnia (r=-0.416) and pain (r =-0.448) showed highest value for significantly
negative correlation to global QoL. In the H&N35 module, restriction of mouth opening (43.3 ± 38.6), dry mouth
(40.7 ± 36.9), sticky saliva (37.3 ± 37.1) and eating in public (33.8 ± 31.9) were the four worst symptoms. Swallowing problem (r=-0.438), eating in public (r=-0.420) and persistent severe speech (r=-0.398) ranked as the three
worst symptoms with highest value for significantly negative correlation to global QoL.
Conclusions: Longterm QoL after oncologic surgery and microvascular free flap reconstruction in patients with
oral cancer is satisfactory. Measuring QoL should be considered as part of the evaluation of cancer treatment.
Key words: Longterm quality of life, oral cancer, oncologic surgery, microvascular free flap reconstruction.
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Introduction

A high score for the functioning scale and for the global QoL scale represents a better level of functioning,
whereas higher levels in the symptom scales or the single-item scales of the EORTC QLQ-C30 and the H&N
module denotes a high level of symptoms or problems.
- Statistical analysis
Statistical analyses were conducted using the SPSS/PC
statistical program (version 22.0 for Windows; SPSS, Inc.,
Chicago, IL). Using the Pearson’s correlation coefficient
(r), we investigated the potential relationships between
QoL global score and general, head and neck symptoms.
In general, r > 0 indicates positive relationship, r < 0
indicates negative relationship, while r = 0 indicates no
relationship (or that the variables are independent and
not related). The strength of relationship is strong for
value of r -1.0 to -0.5 or 0.5 to 1.0, moderate for value of
-0.5 to -0.3 or 0.3 to 0.5, weak for value of -0.3 to -0.1
or 0.1 to 0.3 and none or very weak for value of -0.1 to
0.1. It is well recognised that a correlation between two
variables exists when r is superior to 0.3 and that this
correlation increases as r approaches 1 (6).
Levels of statistical significance have been calculated at
the 5% level of probability (p <0.05).

Generally, the evaluation of cancer treatment is focused
on the survival rate, local control rate, or complication
rate. The main disadvantage is that these endpoints
were usually assessed from the physician´s points of
view. Therefore quality of life (QoL) has become increasingly important in cancer therapy. It refers to the
patient’s perception of the effects of the disease and the
impact of the operation on the patient’s daily functioning. Due to debilitating problems with swallowing and
speech as well as the psychological effects of loss of
function and change in body image, QoL present a decisive role in patients with oral cancer (1). Numerous of
well-validated QoL instruments are established in the
field of oncology. Especially, the European Organization of Research and Treatment of Cancer Quality of
Life Core Questionnaire C30 (EORTC QLQ-C30) and
the Quality of Life Head and Neck module (EORTC
QLQ-H&N35) were frequently used (2,3). Prospective
QoL studies on patients suffering from head and neck
cancer with more than 12 months of follow-up are rare
in the current literature (4,5). The aim of this prospective study was to evaluate long-term QoL after oncologic surgery and immediate microvascular reconstruction
in patients with oral cancer.

Results

A total of 100 patients (69 male, 31 female), mean age
60.1±11.2 years (range 40-83 years), were enrolled in this
study. The location of the tumour and the stage of disease
are shown in table 1. In the majority of cases (42 %), the

Material and Methods

- Study population
The prospective study was initiated after the local ethics committee of the Jena University Hospital gave its
approval. Written informed consent was obtained from
all participants. All patients had histological confirmed
diagnoses of oral squamous cell carcinoma (OSCC)
and underwent surgery at the Jena University Hospital
with curative intent. After intraoral radical resection
and lymph node surgery in accordance with preoperative clinical and radiological examination, all patients
received immediate microvascular free flap reconstruction.
- Assessment of QoL
Patients completed the German versions of the EORTC
QLQ-C30 and the EORTC QLQ-H&N35 at between 12
and 60 months after treatment.
The EORTC QLQ-C30 consisted of five functional
scales (physical function, cognitive function, role function, emotional function and social function), three
symptom scales (fatigue, emesis and pain), one scale
for the overall health status/QoL and six single items
(breathing, sleep disorders, appetite loss, constipation,
diarrhea and economic sequelae) (3).
The EORTC QLQ-H&N35 comprises seven multi-item
scales (pain, swallowing, senses, speech, social eating,
social contact, sexuality) and eleven single items. All
scales and single item variables were transformed into a
score from 0 to 100 (2).

Table 1. Clinical characteristics of the 100 patients.

Clinical characteristics
Tumour-site

Number of
cases (n = 100)

Oral floor

42

Tongue

23

Lower jaw

14

Upper jaw

13

Buccal mucosa

5

Soft palate
UICC-stage

3

I

39
28

II
III
IV

10
23

Operation

e421

Radial forearm flap

62

Scapular flap
Lateral upper arm flap

34

Latissimus dorsi flap

1

3
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tumour was located on the floor of the mouth and 67 out of
100 patients presented with an early stage I/II of disease.
The radial forearm flap was most commonly used (Table
1). In all, adjuvant therapy was indicated in 74 cases. 59
Patients underwent postoperative radiotherapy and further
15 patients received postoperative radiochemotherapy.
- EORTC QLQ-C30
The results of the functional scales are shown in table
2. The mean QoL global score was 58.3 and the mean
score for functioning scale of 76.7.
The results of the general symptom scales and the bivariate
analyses between global QoL score and general symptoms
are shown in table 3. Fatigue (28.7 ± 26.1), followed by financial problems (27.7 ± 33.5), insomnia (26.7 ± 34.5) and
pain (26.3 ± 29.9) were the main general complaints.

- Global QoL score was
• significantly (p<0.05) negative correlated with dyspnea (r=-0.250) and financial difficulties (r=-0.212)
• very significantly (p<0.01) negative correlated with
fatigue (r=-0.488), nausea (r=-0.364), pain (r =-0.488),
insomnia (r=-0.416), appetite loss (r=-0.388), and diarrhea (r=-0.262).
However, global QoL score was not correlated with
constipation.
- EORTC QLQ-H&N35
The results from the EORTC QLQ-H&N35 scales and
items are shown in table 4. Restriction of mouth opening (43.3 ± 38.6), dry mouth (40.7 ± 36.9), sticky saliva
(37.3 ± 37.1) and eating in public (33.8 ± 31.9 ) ranked as
the four worst symptoms.
- Global QoL score was
• significantly (p<0.05) negative correlated with problems with pain medication (r=-0.207), food supplements
(r=-0.237) and weight loss (r=-0.203).
• very significantly (p<0.01) negative correlated with
pain (r=-0.385), swallowing (r=-0.438), speech (r=0.398), social eating (r=-0.420), social contact (r=-

Table 2. Results of the QLQ-C30 overall health status and
functional scales.

Functional scales

Scores

Global QoL

58.3 ± 22.1

Physical functioning

81.3 ± 20.4

Role functioning

68.3 ± 31.5

Emotional functioning

72.0 ± 26.3

Cognitive functioning

84.5 ± 21.1

Social functioning

77.3 ± 28.0

Table 4. Results of the QLQ-H&N35 and the bivariate analyses
between QoL score and symptoms (r-QoL).

Variable

Table 3. Results of the QLQ-C30 and the bivariate analyses between QoL score and general symptoms (r-QoL).

p-value

Scores

r-QoL

Pain

20.7 ± 22.4

-0.385**

<0.01

Swallowing

23.4 ± 25.4

-0.438**

<0.01

Senses

20.5 ± 26.8

-0.147

0.145

Speech

25.6 ± 26.2

-0.398**

<0.01

Social eating

33.8 ± 31.9.
± 31,26,9

-0.420**

<0.01

Social contact

12.9 ± 20.4

-0.405**

<0.01

Sexual problems

31.2 ± 37.6

-0.312**

<0.01

Teeth

17.0 ± 29.4

-0.112

0.266

Open mouth

43.3 ± 38.6

-0.391**

<0.01

Dry mouth

40.7 ± 36.9

-0.186

0.064

Sticky saliva

37.3 ± 37.1

-0.175

0.082

Cough

22.0 ± 28.1

-0.257**

<0.01

Scores

r-QoL

p-value

Fatigue

28.7 ± 26.1

-0.488**

<0.01

Nausea/
vomiting

6.7 ± 16.6

-0.364**

<0.01

Pain

26.3 ± 29.9

-0.448**

<0.01

Dyspnea

16.7 ± 27.4

-0.250*

0.012

Insomnia

26.7 ± 34.5

-0.416**

<0.01

Feeling ill

20.1 ± 29.9

-0.412**

<0.01

Appetite loss

13.7 ± 25.6

-0.388**

<0.01

Pain medication

10.0 ± 15.4

-0.207*

0.039

Constipation

9.0 ± 24.1

-0.195

0.052

Food supplement

6.0 ± 12.9

-0.237*

0.018

Diarrhea

6.3 ± 19.4

-0.262**

<0.01

Feeding tube

6.3 ± 13.1

-0.184

0.068

Financial difficulties

Weight loss

6.3 ± 13.1

-0.203*

0.043

27.7 ± 33.5

-0.212*

0.034

Weight gain

9.0 ± 14.9

-0.060

0.555

Scales

*p<0.05; **p<0.01

*p<0.05; **p<0.01.
e422
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0.405), sexual problems (r=-0.312), open mouth (r=0.391), cough (r=-0.257) and feeling ill (r=-0.412).
There was no correlation between global QoL and problems with senses, teeth, dry mouth, sticky saliva, feeding tube and weight gain.

In the H&N35 module restriction of mouth opening
(43.3 ± 38.6), dry mouth (40.7 ± 36.9), sticky saliva (37.3
± 37.1) and eating in public (33.8 ± 31.9) denote a high
level of problems. The limitation of mouth opening can
be induced by surgical treatment (17,18). Furthermore
the adjuvant radiotherapy is responsible for the limitation of mouth opening long term after treatment and for
salivary dysfunction (19-22). Swallowing problem (r=0.438), persistent severe speech (r=-0.398) and eating in
public (r=-0.420) were significantly negative correlated
with global QoL. These complaints should be properly
identified in order to rehabilitate and nutritionally support patients. Therefore a nutritionist and a rehabilitation therapist should be part of the multidisciplinary
team planning the care of these patients (8). Furthermore, studies reported that that QoL of patients with
OSCC can benefit from psychological group therapy
and psychoeducational treatment (23,24).
Feeling ill (r=-0.412) and pain (r=-0.385) were also significantly negative correlated with global QoL. Chronic
pain is often a consequence of neck dissection and common after surgical treatment (25). Terrell et al. reported
that neck dissection is associated with significant decline
in global QoL (26). Postoperative rehabilitation should incorporated in the standard management in these patients.
Pfister et al. found a significant reduction in pain and
dysfunction in patients undergoing neck dissection who
received weekly acupuncture versus usual care (27).
The design of the current study has some limitations.
We did not subclassify the patients according to the
adjuvant therapy. However, the size of the subgroup
of patients with surgery alone and postoperative radiochemotherapy was too small and inhomogeneous for
comparison of surgical and combined therapy. Furthermore, the focus of this study was to evaluate the effect
of immediate microvascular free flap reconstruction on
long-term QoL.

Discussion

QoL has become a increasingly important in the assessment of any therapy in oncology. There is a rapidly increasing number of published studies investigating QoL
in patients with head and neck cancer (2,5-8). Meanwhile numerous of well-validated QoL instruments are
now available which have been categorized in three
types of methods.The first category includes the generic type, e.g. the Short Form-36 (SF-36), the second
the cancer specific type, e.g. the Functional Assessment
of Cancer Treatment (FACT-G), the EORTC QLQ-C30,
and the third the cancer site-specific type, e.g. the head
and neck modules in EORTC QLQ-H&N35, and FACT
(FACT-HN) (2,3,9-11).
Microvascular free tissue transfers have been used
routinely for head and neck reconstruction in order
to improve the functional and esthetic outcomes (6).
Therefore, the aim of the present study was to evaluate
long-term QoL after surgery and immediate free flap
reconstruction in patients with OSCC.
We used a general QoL questionnaire, adapted to all cancer patients, the EORTC QLQ-C30, and a specific questionnaire, the EORTC QLQ-H&N35 which were completed at between 12 and 60 months after treatment.
Studies showed that surgical treatment of oral cancer
led to a temporary deterioration of QoL issues. However, the levels of these scores improved until the end of
the first postoperative year (7,12). In addition, there are
not any further changes in QoL in the follow years after
treatment (13). Therefore, it is generally accepted that
QoL at one year post-treatment is a good indicator of
QoL at long term in disease-free head and neck cancer
patients (14,15).
With a global QoL score close to 60 %, long-term QoL
of our patients was comparable to the study from Wan
Leung et al. (1). Meanwhile other authors refer to a global QoL score close to 70 % (6,16). Furthermore the mean
score for functioning scale of 76.7 % was similar to the
results from Pierre et al. with a mean score of 82.5 %
(6). Overall, persistent fatigue (28.7 ± 26.1) , followed by
financial problems (27.7 ± 33.5), insomnia (26.7 ± 34.5)
and pain (26.3 ± 29.9) were the main general complaints
of our patients and significantly negative correlated
with global QoL (fatigue: r=-0.488, financial problems:
r=-0.212, insomnia: r=-0.416, pain: r=-0.448). Pierre et
al. and Wan Leung et al. corroborated these results, as
they also refer that fatigue and insomnia are the main
general symptoms (6,1).

Conclusions

The results of the present evaluation with the EORTC
instruments show that longterm QoL after tumor resection and immediate microvascular free flap reconstruction in patients with OSCC seems to be acceptable. The
highest symptom score on QLQ-C30 was for fatigue,
followed by financial problems, insomnia and pain. In
the H&N35 module, restriction of mouth opening, dry
mouth, sticky saliva and eating in public ranked as the
four worst symptoms. Measuring QoL should be considered as part of the evaluation of cancer treatment.
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